In this Issue

In the United States, colds account for more visits to the doctor than any other condition, according to the American Lung Association. The common culprit behind spreading rhinovirus, the virus behind as many as 40% of all colds, is children — pediatric patients on average suffer from the symptoms of a cold between six and eight times each year. And given how highly contagious many colds are, that may explain why many adults get sick, too.

With more Americans reaching their golden years and the country’s healthcare system stressing home care as a way to drive down costs, products to meet these consumers’ conditions are gaining more attention and increasingly finding their way into drug stores’ mix.

(To view the full Home Health Care Report, click here.)

Owen Mumford is releasing an insulin injection guide to better assist healthcare professionals in educating patients on healthy injection routines. Called “Injecting with Insulin: A Guide to Good Injection Technique,” the guide will be offered in both digital and print formats as early as this month.

(To view the full Home Health Care Report, click here.)

As 2016 drew to a close, the Food and Drug Administration gave a gift of sorts to drug makers looking to submit to the agency an application for approval of a biosimilar drug when it issued its final guidance, “Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product.”

(To view the full Category Review, click here.)

The finalized guidance follows the draft guidance the agency issued in May 2014.

America’s selfie-, Instagram- and overall social media-obsessed habits are propelling growth of oral care products promising instant fixes.

(To view the full Category Review, click here.)

After four decades in retailing, Panzer has been lucky enough to have a number of great mentors in business, but the Albertson’s healthcare chief tells DSN some of the most important lessons he ever learned came as a young cowhand on his grandmother’s Santa Fe ranch.

A number of recent product offerings in the VMS space may represent white-space opportunities — or products that help create a marketing or merchandising niche that resonates with today’s consumer.

Overall, sales of multivitamins are relatively flat — 0.2% annual growth toward a $1.8 billion base. But according to the latest consumer survey from the Council for Responsible Nutrition, 3-in-4 adults use a multivitamin. So, have sales of multivitamins plateaued, or are there pockets of opportunity out there?